About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Global Fund Policy Encouraging Drug Resistance

by Medindia Content Team on May 15, 2006 at 12:09 PM
Font : A-A+

Global Fund Policy Encouraging Drug Resistance

WHO has warned Global Fund, the world's leading funder of treatments for infectious disease, that its current policy of Treating AIDS, Tuberculosis and Malaria carried a risk of causing drug resistance.

Kochi Arata, head of the WHO's malaria programme referring to the compliance list of drugs circulated by the Global Fund which contains advice on the malaria drug artemisinin. It has been found that Artemisinin was effective in treating the worst cases of malaria even the strains of the malarial parasite that had developed resistance to all other drugs.

Advertisement

However as health experts warn the use of this drug as a 'monotherapy', that is without a second drug, would foster resistance, leaving no alternative medicine to treat the resistant parasite.

The Global Fund's compliance list cites several such monotherapies where the manufacturing is of good quality and is used as a guide for countries purchasing these malaria drugs. WHO had launched an appeal to stop monotherapy, urging manufacturers to stop producing artemisinin alone, and on countries to ban its use.13 of the 40 manufacturers of artemisinin therapy that the WHO identified have agreed to cease its production.
Advertisement

Mr Arata expressed concerns that others might seek to exploit the gap created by the Global Fund's compliance list and boost their own monotherapy sales. Although several countries have also agreed to withdraw marketing authorisation from monotherapies to ban their use, 49 have not.

According to him China both uses and produces large amounts of artemisinin which was a major issue of concern. In addition Mr Arata criticised the 'unsatisfactory' response of the Global Fund to the WHO's demands that it change its compliance list.

Global Fund has defended themselves claiming that they would follow whatever advice the WHO gave to countries it funded. However it argued that its list was not compulsory and only reflected the guidelines of the WHO. WHO does not agree, arguing that the list results in misuse and confusion, provides unnecessary endorsement for drugs and is used for marketing by monotherapy manufacturers.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Third Party Administrator for Claims and Cashless Health Insurance 

Most Popular on Medindia

Diaphragmatic Hernia Sanatogen Color Blindness Calculator Find a Hospital Indian Medical Journals Post-Nasal Drip Pregnancy Confirmation Calculator Daily Calorie Requirements Nutam (400mg) (Piracetam) Accident and Trauma Care
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Global Fund Policy Encouraging Drug Resistance Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests